Stay updated on Finerenone in HF with LVEF ≥40% Clinical Trial
Sign up to get notified when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.

Latest updates to the Finerenone in HF with LVEF ≥40% Clinical Trial page
- Check6 days agoChange DetectedAdded two 2026 publications with author lists and DOIs to Publications, removed one earlier citation, and updated the page revision to v3.4.3.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded three publications to the Publications section: Nat Med 2024; Eur Heart J Cardiovasc Pharmacother 2026; JAMA Cardiol 2025. Removed three publications: Nat Med 2024; JACC Heart Fail 2025; JAMA Cardiol 2025.SummaryDifference0.1%

- Check29 days agoChange DetectedPublications section now includes a new 2026 JACC Heart Fail citation (with authors) and updates the prior Eur J Heart Fail citation to a later version. This updates the study’s referenced literature and author information.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page adds a Circ Heart Fail publication (2026 ahead of print) and updates the revision tag to v3.4.1, replacing v3.4.0. These are minor metadata updates that do not alter core study content, eligibility criteria, or outcomes.SummaryDifference0.0%

- Check43 days agoChange DetectedAdded the 2026 JACC Heart Fail publication by Ostrominski et al. titled 'Finerenone and NYHA Functional Class in Heart Failure: The FINEARTS-HF Trial' and removed the 2025 online-ahead-of-print citation with the same topic.SummaryDifference0.0%

- Check51 days agoChange DetectedThe Study Details page has new labels 'Results First Posted' and 'Last Update Posted' in the Study Record Dates, and the '(Estimated)' variants have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Finerenone in HF with LVEF ≥40% Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.